Hologic (HOLX) Announces Favorable Ruling in SenoRx Patent Infringement Suit
Tweet Send to a FriendGet Alerts HOLX Hot Sheet
Down)
Trade HOLX Now!
Hologic (Nasdaq: HOLX) shares are trading just off session highs as the company announced a favorable ruling in its patent infringement suit related to SenoRx.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Intuitive Surgical (ISRG) Jury Reaches Positive Verdict in Robot Case; Shares Rise
- Hologic (HOLX) Announces FDA Approval of C-View 2D Imaging for or Breast Cancer Screening
- First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection
Create E-mail Alert Related Categories
Litigation, Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
